Stephen Caltabiano,Eliot Ohlstein,Stewart McCallum
申请号：
US16428657
公开号：
US20190365683A1
申请日:
2019.05.31
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to methods of treating overactive bladder and the symptoms associated therewith, for example, urinary urgency, frequency of micturitions, nocturia, and urgency urinary incontinence. One treatment method according to the present invention comprises treatment with the beta-3 adrenergic receptor agonist solabegron. Another treatment combination according to the invention comprises solabegron, and a muscarinic receptor antagonist which results in a synergistic effect on the symptoms associated with OAB.
